Atossa Therapeutics Inc (ATOS)

08:40 AM

Rodman & Renshaw initiates Atossa Genetics stock with buy rating By Investing.com - Investing.com Canada

08:40 AM

Jul 06, 2026

ATOSAtossa Therapeutics Inc Short Interest - Finviz

Jul 06, 2026

Jul 02, 2026

ATOS Stock Drops After Hours On Earnings Miss — CEO Now Bets On New Uses For Its Experimental Cancer Drug - Stocktwits

Jul 02, 2026

Jun 29, 2026

Atossa Therapeutics, Inc.(NasdaqCM:ATOS) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Price to book forward of Atossa Therapeutics, Inc. – NASDAQ:ATOS - TradingView

Jun 29, 2026

Jun 29, 2026

Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Atossa Therapeutics, Inc. adopts integrated biologic signals to advance breast cancer research - Traders Union

Jun 26, 2026

Jun 26, 2026

Price to sales forward of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Jun 26, 2026

Jun 26, 2026

Price to book forward of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to EBITDA forward of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Jun 26, 2026

Jun 26, 2026

ATOS Should I Buy - Intellectia AI

Jun 26, 2026

Jun 25, 2026

Atossa Therapeutics, Inc. (NASDAQ:ATOS): Are Analysts Optimistic? - simplywall.st

Jun 25, 2026

Jun 22, 2026

Atossa Therapeutics Inc (ATOS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026

Jun 19, 2026

Atossa Therapeutics raises $4.5M in registered direct offering By Investing.com - Investing.com Nigeria

Jun 19, 2026

Jun 18, 2026

Atossa Therapeutics Inc (ATOS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026

Jun 18, 2026

Atossa Therapeutics Inc (ATOS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026

Jun 18, 2026

Atossa Therapeutics Inc (ATOS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026

Jun 17, 2026

Atossa Therapeutics Inc (ATOS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Atossa Therapeutics Inc (ATOS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Atossa Therapeutics Inc (ATOS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

Atossa Therapeutics Inc (ATOS) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 17, 2026

Atossa Therapeutics Inc (ATOS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 15, 2026

Atossa Therapeutics brings medical innovation to Hudson Institute strategic discussions - Traders Union

Jun 15, 2026

Jun 13, 2026

Atossa Therapeutics (ATOS) Q1 2026 Earnings: Narrowing Losses with Positive EPS SurpriseRevenue Warning Signal - newsline.com

Jun 13, 2026

Jun 13, 2026

Atossa Therapeutics closes $4.5M registered direct offering By Investing.com - Investing.com Australia

Jun 13, 2026

Jun 12, 2026

Atossa Therapeutics closes $4.5M registered direct offering - Investing.com

Jun 12, 2026

Jun 12, 2026

Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds - PR Newswire

Jun 12, 2026

Jun 12, 2026

Atossa Therapeutics Announces Up To $16.5 Million Registered Direct Offering - Pulse 2.0

Jun 12, 2026

Jun 12, 2026

Atossa Therapeutics examines biosecurity and scientific innovation after COVID 19 lessons - Traders Union

Jun 12, 2026

Jun 12, 2026

Atossa Therapeutics (NASDAQ: ATOS) sells 1.36M shares with warrants in $4.5M deal - Stock Titan

Jun 12, 2026

Jun 11, 2026

Market Movers | Winners: XXII, PPCB, CCHH | Losers: BCPC, ATOS, BATL - Trefis

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics, Inc. (ATOS) Latest Stock News & Headlines - Yahoo Finance

Jun 11, 2026

Jun 11, 2026

Top Midday Decliners - Moomoo

Jun 11, 2026

Jun 11, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Jun 11, 2026

Jun 11, 2026

Crude Oil Edges Higher; Driven Brands Posts Upbeat Earnings - Benzinga

Jun 11, 2026

Jun 11, 2026

Dow Jumps Over 250 Points; US Initial Jobless Claims RiseAtossa Therapeutics (NASDAQ:ATOS), Big Tree C - Benzinga

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics Launches $16.5 Million Registered Direct Offering - marketscreener.com

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics stock tumbles on $4.5M stock offering - Investing.com UK

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics Announces Registered Direct Offering and Warrants - TipRanks

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics stock tumbles on $4.5M stock offering By Investing.com - Investing.com Nigeria

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics raises $4.5M in registered direct offering - Investing.com

Jun 11, 2026

Jun 11, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market SessionAditxt (NASDAQ:ADTX), Atossa Therapeutics - Benzinga

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics Prices Registered Direct Offering at $3.30, Netting About $4.1 Million - TradingView

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics (ATOS) prices $3.30 registered direct stock and warrant sale - Stock Titan

Jun 11, 2026

Jun 11, 2026

Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds - PR Newswire

Jun 11, 2026

Jun 10, 2026

Atossa Therapeutics highlights Endoxifen progress as potential Breast Cancer treatment - Proactive financial news

Jun 10, 2026